Transforming Healthcare Access with Simple Health Kit and Mark Cuban Partnership Discover how Dr. Sheena Menezes and Simple Health Kit are revolutionizing healthcare through community-centered platforms, innovative lab kits, and a strategic partnership with Mark Cuban's Cosplus Drug Company. This episode details the vision for equitable access and the integration of technology in healthcare. In this episode: - The foundation and mission of Simple Health Kit in providing accessible healthcare - How the platform partners with enterprises to engage underserved populations - The significance of Mark Cuban’s Cosplus Pharmacy partnership and its impact on medication affordability - The origin story of Sheena Menezes: from Kuwait refugee to healthcare innovator - The role of digital and physical channels in delivering health kits and lab testing - Vision for the future: bringing high-quality, personalized healthcare to rural and underserved areas - The importance of primary care access, especially in rural health settings - The influence of technology, including AI and community-focused models, in preventive care Timestamps: 00:00 - Welcome and overview of Simple Health Kit's mission 00:36 - How Simple Health Kit puts individuals at the center of care 01:43 - Major announcement: partnership with Mark Cuban’s Cosplus Drug Company 02:08 - Benefits of the partnership for medication access and affordability 02:53 - Sheena Menezes' inspiring origin story 03:21 - The drive to bring care to those who need it most 03:53 - The growth and scale of Simple Health Kit over seven years 04:16 - How patients can access Simple Health Kit products via health plans, stores, and online 04:45 - Physical in-store health kits and direct-to-consumer options 05:04 - The range of lab testing available: diabetes, kidney, cancer, STI 05:24 - Strategic channels: payers, providers, and pharmacies 05:28 - Vision for universal healthcare access in the next decade 06:03 - Focus on high-level, concierge care in underserved areas 06:32 - Exciting future developments and Mark Cuban connection Resources & Links: https://www.simplehealthkit.com/ Connect with Dr. Sheena Menezes: https://www.linkedin.com/in/sheenamenezes/

Show Notes What if the most valuable data in healthcare has been sitting in plain sight the entire time, buried inside millions of clinical notes no one can actually use? Live from ViVE, Marcus Gordon sits down with Dr. Tim O’Connell, co-founder and CEO of Emtelligent and a practicing radiologist, for a conversation about one of the biggest blind spots in modern healthcare: unstructured data. Dr. O’Connell breaks down why health systems are overflowing with information yet still starving for actionable insight, and why unlocking clinical notes at scale could change everything from patient care to cost control to real-world evidence. This episode gets into the real tension behind AI in healthcare. The technology is moving fast, but the stakes are too high for blind automation. Diagnoses, claims, treatment decisions, and chart review cannot become black-box exercises. Dr. O’Connell makes the case for clinician-led AI, where humans stay firmly in control and technology does what it does best: surface critical information faster, more accurately, and at scale. The conversation also explores why radiology has long been seen as a digital pioneer, why AI adoption in clinical workflows may actually be moving faster than in imaging, and what it will take for health systems, payers, and life sciences companies to responsibly share data in ways that improve care without compromising trust. This is a conversation about where healthcare is actually headed, not in theory, but in practice. In this episode: Why an estimated 80% of healthcare data lives in unstructured clinical notes The real reason health systems are data rich but insight poor Why human-in-the-loop AI is non-negotiable in healthcare How AI-assisted chart review can reduce friction for clinicians Why radiology may not be the AI leader people assume it is What better data sharing could mean for cost, quality, and real-world evidence Why the future of healthcare depends on turning documentation into decisions

Healthcare has talked about AI for years. What feels different now is that the conversation is finally moving toward practical use cases. In this episode of Boombostic Health, Marcus Gordon sits down with Dr. Luke Hansen of Arcadia at HIMSS to discuss where AI is beginning to create real value in healthcare. They explore how AI can help expand access, support care teams, surface more meaningful patient context, and identify rising risk earlier. This conversation goes beyond the usual hype. Dr. Hansen explains the difference between tools that improve efficiency, like summarization and documentation support, and the more meaningful long-term shift toward predictive and agentic capabilities that could reshape care delivery. For healthcare leaders, operators, and innovators trying to separate real operational value from noise, this is a thoughtful conversation worth watching. In this episode: - Why healthcare AI is becoming more practical - How AI can help expand access to care - The shift from summarization to predictive and agentic tools - Why trust and safeguards matter more than hype - What healthcare leaders should watch as adoption evolves #BoombosticHealth #HealthcareAI #HIMSS #DigitalHealth #PopulationHealth #HealthTech #CareManagement

Healthcare does not have a clinical excellence problem. It has an execution problem. In this episode of Boombostic Health, Bradley Bostic sits down with Dr. David Atashroo of Qventus live from ViVE 2026 to talk about the hidden layer of healthcare that determines whether care actually works: operations. The United States leads the world in clinical innovation. Yet patients still face delays, canceled procedures, fragmented care, and repeated administrative friction. Why? Because healthcare was never designed to operate efficiently across the full care continuum. This conversation explores how AI is beginning to fix that. Instead of just generating insights or dashboards, a new generation of AI platforms is helping health systems orchestrate the work surrounding care delivery — from access and scheduling to surgical preparation, inpatient flow, discharge coordination, and care gap closure. If healthcare is going to improve outcomes, reduce costs, and restore clinician capacity, it will require more than better tools. It will require operational intelligence embedded across the entire system. In this episode we discuss: • Why the biggest problems in healthcare are operational, not clinical • How AI can coordinate care across the full patient journey • Why value-based care often fails to execute • The hidden costs of administrative friction in hospitals • How health systems can reduce length of stay and improve patient experience • What the future of AI-driven care operations could look like Key Insight “If you can make the right thing to do the easy thing to do, you advance value-based care.” 🎧 Subscribe to Boombostic Health for more conversations with leaders shaping the future of healthcare.

Episode Summary Recorded live at ViVE 2026 in Los Angeles, Bradley Bostic sits down with Dave Newman (Digital Health) and Brad Reimer (CIO) from Sanford Health to explore how one of the nation’s largest rural health systems is redefining care delivery. Serving 2 million patients across 320,000 square miles, Sanford Health is proving that innovation doesn’t only happen in major urban health systems. From virtual care infrastructure funded by a $350M investment to AI tools that restore the human connection between doctors and patients, Sanford is building a new model for rural healthcare. The conversation explores how virtual care, AI, and data governance are helping clinicians spend more time with patients while expanding access across the Upper Midwest. A key insight: technology works best when it returns healthcare to what matters most — the relationship between doctor and patient.

Recorded live at ViVE, Marcus Gordon guest hosts for Bradley Bostic and talks with Amy Gleason about where healthcare AI is actually headed—and what has to be true for it to work. We’ve been “empowering patients” for a long time in theory. AI is the first thing that’s made it feel real at scale. But Amy makes a key point: if AI doesn’t have the right data under it, it’s basically just a faster version of “Dr. Google.” This episode gets into interoperability, why standards still matter, what privacy and consent should look like in plain English, and how patients could use AI to navigate care anytime—like a Saturday night when you’re not sure if something is urgent. Amy also shares a personal story about her daughter using AI to review old records, spot a misclassification, and reopen a path into a clinical trial. It’s a great reminder: the future isn’t just chatbots. It’s access + context + trust. What you’ll hear Why AI is finally making patient empowerment real The “Dr. Google” problem (and how to get past it) Why interoperability is the foundation for personalized AI Why standards like FHIR still matter What “clear consent” should look like for patients How AI can surface insights buried in years of medical history What healthcare could look like when patients can get help anytime #ai #healthcare #digitalhealth #patientempowerment #healthcareinnovation #healthcarepolicy #healthcaretechnology #ViVE

Show Notes Recorded live at ViVE, Bradley Bostic sits down with Aneesh Chopra, the first Chief Technology Officer of the United States, entrepreneur, and former Obama administration tech leader who helped open up Medicare data to the public. This conversation explores what happens when government transparency, private-sector innovation, and AI collide. Aneesh shares: Why “open data” in healthcare became the default and why it was always bipartisan How his company CareJourney turned Medicare data into physician performance intelligence and why it mattered What “outcomes as a service” could mean for the next era of payment reform A real-world example of AI voice agents helping a medical center jump from 2 to 4 Stars in 90 days Why actuarial math alone won’t scale value based care The concept of a “health information fiduciary” aligned with patients, not billing codes How AI front ends could deliver high-touch engagement to every patient, not just the highest risk 10 to 15 percent Aneesh makes a bold claim: We constrain care today because it is labor intensive. But if AI agents can deliver hundreds of touchpoints per week, escalate when necessary, and guide patients along protocol driven pathways, value based care becomes abundant and scalable at a fraction of the cost. He is not talking about theory. He is already using conversational AI to securely summarize his own medical record and labs. The infrastructure is here. The data is open. The agents are live. The only question is whether we will align incentives fast enough to let this scale.

Blood Health Is the Bottleneck (with Sherri Ozawa) — World Anemia Awareness Day Special Summary Ahead of World Anemia Awareness Day (Feb 13), we’re resurfacing a timely conversation with Sherri Ozawa, Director of Clinical Operations and Delivery at hc1, on blood health and Patient Blood Management (PBM). We unpack why blood health is often overlooked, where decisions break down in real workflows, and what it takes to make PBM programs stick. Note: This is an updated video cut. Audio is unchanged from the original release. In this episode * PBM in plain English: what it is and why it matters * Why anemia and iron deficiency are often missed * Where blood-related decisions break down (screening, handoffs, follow-through) * What “good” looks like when PBM is built into workflow—not added on * Practical steps teams can take to improve consistency and execution About the guest Sherri Ozawa is the Director of Clinical Operations and Delivery at hc1. She works at the intersection of clinical execution and operational adoption—helping teams turn good ideas into repeatable workflows. Resources * World Anemia Awareness Day: https://worldanemiaawareness.com/ * ASPBM: https://aspbm.net/ * CAP TODAY (Aug 2025): https://www.captodaymag.com/captoday/library/item/august_2025/4288696/ Disclaimer This episode is for informational purposes only and is not medical advice. Call to action Where does “blood” break down most in your workflow—screening, handoffs, or follow-through? Drop a comment and tell us what you’re seeing.

Insurance funded therapy often ends fast. Recovery does not. In this follow up episode, Bradley Bostic talks with Chris Leeuw, CEO of NeuroHope, about the “rehab cliff” facing spinal cord injury, brain injury, stroke, and MS patients when they leave inpatient care and quickly run out of covered visits. Chris shares what NeuroHope is building in Indianapolis to keep recovery going: a model that blends skilled therapy, trained kinesiologists, adaptive fitness, and a true community so patients can continue progressing long after insurance stops paying. They also unpack the expanding vision behind the Driven Neuro Recovery Center, developed with the Conquer Paralysis Now, and why this kind of recovery ecosystem is becoming essential infrastructure for the disability community. In this episode, you’ll learn Why “30 visits” is not neuro recovery How NeuroHope makes long term therapy more affordable after coverage runs out What’s changed since last year including 30 percent growth in services Early outcomes from a two year study tracking complications and readmissions Why community is often the difference between surviving and thriving What’s emerging in rehab tech including trans spinal stimulation and what it could unlock The bigger campus vision and what partners could help make possible Help NeuroHope close the rehab gap If you believe recovery should not end when insurance does, here are three simple ways to help: 1. Watch and share this episode Send it to one person navigating stroke, spinal cord injury, or brain injury recovery, or to a clinician who needs a better option to refer to. 2. Support NeuroHope’s mission NeuroHope relies on community support to keep long term therapy accessible after coverage runs out. If you’re able, consider donating or becoming a sponsor. 3. Partner in Indianapolis NeuroHope is building a broader recovery ecosystem and is looking for aligned partners across adaptive sports, mental health, vocational rehab, DME, and innovative rehab technology. Guest Chris Leeuw is the CEO of NeuroHope, focused on expanding access to long term neuro recovery through therapy, wellness, and community. View the NeuroHope Wellness Center: https://www.youtube.com/watch?v=0k5p3kLL2_A Learn more about NeuroHope: https://www.neurohopewellness.org/

🤔 Did you know that 30-50% of Americans lack access to primary care? That's a staggering number! Bradley Bostic sits down with Matthew Holt (The Health Care Blog) for a blunt diagnosis of what’s broken in U.S. healthcare — and a concrete, numbers-driven proposal to fix it. Holt doesn’t just complain. He names incentives, calls out the money flows, and lays out a primary-care “voucher” model designed to cut downstream costs while making primary care a top-tier, high-status job again. If your organization is still treating primary care like a loss leader and “leakage” like a KPI, this one will sting (in the right way). Timestamps 00:00 – 01:20 HLTH 2025 setup + dark humor about “keeping subscribers alive” 01:20 – 05:30 Holt’s blunt system diagnosis + “nonprofit” and executive pay critique (UPMC example) 05:30 – 08:45 Primary care access crisis + why the ER becomes the default front door 08:45 – 10:50 “Leakage” + the referral-engine reality inside employed primary care 10:50 – 13:15 The concierge-for-all voucher model (the simple math) 13:15 – 16:30 Bradley connects it to value-based care + incentive shifts 16:30 – 18:10 Wrap: fewer complaints, more solutions + where to follow Holt What you’ll hear Why the U.S. system is expensive by design — and why consumers carry the anxiety. The uncomfortable truth about “nonprofit” health systems, executive comp, and transparency. How primary care got turned into a referral engine for high-margin services. Holt’s two-step path to reform — including a “concierge-for-all” model with simple math behind it. Where this intersects with value-based care… and where today’s versions still fall short. To learn more about The Healthcare Blog, visit here: https://thehealthcareblog.com/blog/category/health-tech/matthew-holt/

Guest: Fawad Butt, Founder & CEO, Penguin AI (former CDO/data leader across major payer/provider organizations) Healthcare isn’t broke because we lack innovation. It’s broke because we spend a staggering amount of money moving paper, arguing over rules, and chasing “documentation” instead of outcomes. From the HC1 booth at Health 2025 in Vegas, Bradley sits down with Fawad—a veteran healthcare data operator turned founder—to talk about the real enemy: administrative waste at trillion-dollar scale… and why slapping GPT on top of messy systems just gives us a confident-sounding parrot. Penguin AI is building an AI-first healthcare platform designed to run workflows end-to-end across payers and providers—prior auth, revenue cycle, claims, coding, and more—without forcing teams to become AI engineers. Notable moments (timestamps) 00:00 — Live from Health 2025 in Vegas: meet Fawad, founder of Penguin AI 00:26 — From big-company data leadership to startup founder 01:48 — The brand: why “Penguin” (and why most tech names are nonsense) 04:34 — The core problem: admin work at massive scale (prior auth, claims, RCM, scheduling) 06:00 — “Dr. GPT”: why it sounds right even when it’s wrong 07:31 — Funding + momentum: Penguin’s Series A and growth 08:00 — Building better clinical intelligence requires real healthcare-grade data 09:28 — Operator-to-founder: why more insiders need to jump into the arena 11:50 — What Penguin actually does: agents, customization, and “platform-level” scale 14:05 — Why payer vs provider is a false divide What you’ll hear in this episode Why “AI in healthcare” is mostly theater if your data is fragmented, dirty, and politically guarded The uncomfortable truth: administration is the cost center eating the system alive Why GPT can sound brilliant and still be dangerously wrong (“a very smart fairy”) The case for healthcare-specific platforms (not generic clouds + hope) Why “payer vs provider” is an outdated segmentation—and processes prove it Founder reality: leaving big-title comfort for the zero-to-one grind The Penguin story: branding that grabs attention and signals how hard healthcare change really is Who this episode is for: Health system and payer leaders drowning in prior auth, claims, RCM, coding, and operational drag Operators skeptical of hype who want real automation + measurable cost reduction Founders building AI in healthcare who are ready to confront the data + workflow reality Investors looking for platforms that can win beyond “pilot purgatory” #HealthcareAI #HealthTech #AIinHealthcare #HealthcareOperations #DigitalHealth

IU Health CEO Dennis Murphy joins Bradley Bostic to unpack what it takes to drive innovation at scale—across 16 hospitals and 300+ clinical sites. They cover values-based culture, platform-first AI strategy, statewide data collaboration, philanthropy as a “margin of excellence,” and IU Health’s new flagship campus—set to see its first patients in December 2027. Chapters 00:00 Introduction to Healthcare Innovation 01:56 Leadership and Organizational Values 04:50 Flagship Hospital Project Overview 08:18 Optimism in Healthcare 12:08 Technology and AI in Healthcare 17:40 Philanthropy and Community Impact 23:13 Data Utilization in Healthcare 28:37 Personalization of Healthcare Experience 34:53 Future of IU Health and Closing Remarks In this episode of Boombostic Health, Bradley Bostic sits down with Dennis Murphy, President & CEO of IU Health, for a candid conversation on what it takes to execute healthcare innovation at true scale—without losing culture, safety, or the human side of care. Dennis shares how leading a system spanning 16 hospitals and 300+ clinical sites requires a different discipline: moving from a rules-based organization to a values-based organization, where culture becomes “self-policing” because the expectations are clear. He breaks down IU Health’s four core values—serve with purpose, compassion, excellence, and be a great team member—and explains why “excellence” must explicitly include innovation. From there, Bradley and Dennis go deep on IU Health’s new flagship campus project, why it’s not one project but five, and how it’s designed to solve a real strategic problem: putting top talent together in one place and competing nationally for physicians, researchers, and clinical leaders. Dennis also explains the operational reality behind major facilities—like training teams for a brand-new environment and connecting 52,000 networked devices safely before the first patient arrives. The conversation expands into why Dennis remains optimistic about healthcare after 35+ years in the industry—pointing to tangible progress in outcomes, preventive health, and the growing recognition that care extends beyond hospital walls into behavior, environment, and social determinants. They also tackle the technology question every health system faces: platforms vs. point solutions. Dennis outlines how IU Health thinks about AI investments—leaning into platform foundations like the EHR/EMR, ERP, ambient listening, and ambient video, while still pursuing targeted tools when the patient impact is undeniable (including AI-enabled support for surgical precision in complex cases). Finally, Dennis highlights IU Health’s deep roots in philanthropy—why it’s the “margin of excellence” that funds differentiated programs and world-class clinical talent—and shares why Indiana’s collaborative approach to data (including statewide exchange efforts) matters for safety, continuity, and better outcomes. First patients in the new hospital are planned for: December 2027. What you’ll hear in this episode What changes when you go from “walking the halls” leadership to leading across a statewide footprint Why IU Health shifted from rules-based to values-based culture—and what that unlocks The real strategic reason behind the flagship campus: talent density + national competition Why the new campus is “five projects,” not one—and what “ready for patients” actually requires Dennis’ framework for AI investments: platform foundations first, point solutions where outcomes demand it How ambient listening/video and enterprise platforms can drive system-wide operational improvement Why healthcare progress is real—and why optimism is rational (even with cost pressure) Philanthropy as the “margin of excellence” that funds unique talent and programs Why data sharing across competitors is a patient-safety advantage—and how Indiana made it work The next wave of personalization: moving from reactive care to proactive prompts and closed-loop follow-up #boombostichealth #digitalhealth #healthcareinnovation

At-home diagnostics isn’t “a kit.” It’s an operating system. From the outside, it looks simple: order → kit arrives → collect → mail back. Behind the scenes, scaling that experience requires automation, reliability, and speed. In this conversation, Jeff Shattuck explains how DOT Corp uses automation, robotics, and AI to reduce the time from order to shipment, expanding what’s possible for home diagnostics and precision medicine. Key moments DotCorp transitioned from printing to healthcare logistics. AI and robotics are streamlining healthcare processes. At-home testing is becoming more prevalent post-COVID. Less invasive testing methods are emerging. Precision medicine will rely on at-home diagnostics. Accountable care programs are driving demand for home testing. Collaboration with major labs enhances service delivery. Patient empowerment is key in modern healthcare. Chapters 00:00 The Entrepreneurial Journey of DotCorp 05:19 Transforming Diagnostics: Home Testing Revolution 07:46 The Future of Precision Medicine and Home Testing Connect Jeff Shattuck: https://www.linkedin.com/in/jeffoshattuck/ Bradley Bostic: https://linktr.ee/BradleyBostic Boombostic Health: https://www.boombostichealth.com/ #boombostichealth #diagnostics #labtesting #digitalhealth #healthcareinnovation #populationhealth #valuebasedcare #precisionmedicine #healthcareoperations #supplychain #healthtech #hlth2025

Show Notes Healthcare keeps talking about AI, affordability, and outcomes… But most systems are still ignoring the front door that drives care decisions: diagnostics. Recorded In the Wild at HLTH 2025 in Las Vegas, Bradley Bostic sits down with James York (Chief Commercial Officer + Head of Government Affairs, Molecular Testing Labs) to unpack a hard truth: If you can’t make testing accessible, convenient, and trackable… you can’t build reliable care pathways. In this episode, James breaks down why diagnostics is a flywheel—the top-of-funnel that activates patients—and why “we have Quest/Labcorp, so we’re good” is the exact mindset keeping innovation stuck. He also shares how Molecular Testing Labs attacked the hardest access problem first (HIV/STI), what happened when they removed friction from PrEP care, and why lab-based at-home testing matters because it protects the integrity of the data (not just the experience). You’ll also hear a forward-looking take on self-collection, routine testing for chronic disease + wellness, cost transparency, and where AI could take us next—toward forecasting health like we forecast weather. What you’ll learn: Why James calls diagnostics “the flywheel” for activating patients The two stats that should change how leaders budget for labs (“70% of clinical decisions” vs “7% of spend” — as James cites) Why self-collected, lab-processed testing beats “rapid-only” testing when data/reporting matters How at-home testing can reduce stigma and improve public-health surveillance What “patient-as-decision-maker” healthcare could look like in the next 5–10 years If you care about prevention, care gaps, data integrity, and making healthcare actually work for more people—this one’s for you. Chapters 00:00 — Boombostic Health “In the Wild” @ HLTH 2025 (Vegas) 00:45 — Baseball dads, real life, and the cost of ambition 02:05 — “Everyone should have access to diagnostics” (mission) 03:00 — Why the “Diagnostic Zone” is a signal moment 04:30 — The stat gap: labs drive decisions, not spending 05:45 — Why they started with HIV/STI (the hardest use case) 07:30 — Self-collection scale + what it unlocked for access 08:10 — PrEP friction: stigma + testing barriers (and the unlock) 09:45 — The Abbott at-home multiplex test: what’s new + why it matters 11:05 — Rapid vs lab: the real issue is data integrity + reporting 12:40 — What’s next: routine tests, chronic disease, wellness expansion 16:15 — AI, avatars, and “forecasting health like weather” 18:10 — Bradley’s lens: signals, patterns, and getting patients on the right interventions 20:34 — Wrap + why data in will determine everything #boombostichealth #hlth2025 #diagnostics #moleculardiagnostics #labtesting #preventivecare #publichealth #healthcareinnovation #digitalhealth #aiinhealthcare #stitesting

Healthcare is racing to be “AI ready.” But most of the industry is still trying to turn billing exhaust into strategy. In this episode, Bradley Bostic sits down with Ryan Leurck, Co-Founder & Chief Analytics Officer at Kythera Labs, to cut through the noise and get blunt about what actually makes AI work in healthcare. Because the truth is simple—and uncomfortable: If your data can’t be trusted by humans, it can’t be trusted by AI. And in healthcare, much of our data was never designed for the questions we’re now demanding it answer. Takeaways Why claims, EHR, and lab data weren’t built for strategy—and how that limits AI. The risk of modern AI: “AI is not always right, but it always sounds sure.” Why healthcare data is still optimized for coding and billing, not predictive insight. Kythera’s mission to “reduce the uncertainty in the use of healthcare data.” How leaders should think about “AI ready” without falling for hype. The reality of claims: a “big bag of receipts” that can mislead without expert context. A practical vision for AI inside provider orgs: agents that function like analysts/interns, not decision-makers. Chapters 00:00 Introduction to AI in Healthcare 01:23 Ryan Leurck's Journey from Aerospace to Healthcare 03:22 The Current AI Landscape and Its Misconceptions 06:54 Kythera Labs: Reducing Uncertainty in Healthcare Data 11:13 Challenges of Healthcare Data and AI Integration 18:03 Opportunities for AI in Healthcare 22:52 Kythera's Target Audience and Solutions 27:41 The Role of AI in Operational Efficiency 31:18 Data Privacy and Accessibility in Healthcare 34:30 The Future of AI in Healthcare #boombostichealth #healthcareai #healthdata #dataanalytics #digitalhealth #machinelearning #aiinhealthcare #healthtech #healthcareinnovation #valuebasedcare #patientoutcomes #healthcareleadership

Summary By the time most people hear “dementia,” their brain has been sounding the alarm for years. In this episode of Boombostic Health, Dr. John Showalter shares his journey from internist to healthcare technology innovator. He explains how AI and digital tools can support early detection and intervention for cognitive decline—before daily life starts to fall apart. The conversation highlights how lifestyle changes can improve cognitive health, why screening the brain should be as routine as checking blood pressure, and how integrating technology into healthcare systems can scale better outcomes. Real-life success stories show what’s possible when you catch problems early and give people a path to act. Takeaways Dr. Showalter’s journey from medicine to healthcare technology is inspiring. AI can enhance caregiver efficiency and patient care. Early detection of cognitive decline is crucial for effective intervention. Lifestyle changes can significantly impact cognitive health. Integration of technology into healthcare systems is essential for scalability. Personalized brain health action plans can improve patient outcomes. Social isolation and loss of purpose are key factors in cognitive decline. Real-life success stories demonstrate the effectiveness of early intervention. Healthcare innovation requires collaboration between technology and clinical expertise. The future of cognitive health lies in proactive, lifestyle-based approaches. Chapters 00:00 Innovating Healthcare: A Journey into Technology 02:39 The Role of AI in Patient Care 05:34 Cognitive Health: Early Detection and Intervention 08:24 Lifestyle Changes and Cognitive Decline 11:07 Integrating Technology into Healthcare Systems 14:08 The Future of Cognitive Health and AI 17:03 Real-Life Success Stories in Cognitive Health About Dr. Showalter Dr. John Showalter is an internist and clinical informatics leader who has been obsessed with the data side of care since his first DNA research job at 14. Trained in biomedical engineering and medical informatics, he went on to lead major EHR implementations and build a state-of-the-art analytics center from a $0 to $6.5M budget, earning a Premier 100 IT Leaders award along the way. Today, he focuses on turning complex data and AI into practical tools clinicians actually use, helping detect disease earlier and improve patient outcomes at scale. Resources Linus Health – digital cognitive assessment and brain health platform: https://www.linkedin.com/company/linus-health/posts/?feedView=all Connect with Dr. John Showalter on LinkedIn: https://www.linkedin.com/in/johnshowaltermd/ Boombostic Health podcast – more episodes on AI, diagnostics, and the future of care: https://www.boombostichealth.com/podcast #dementia #brainhealth #earlydetection #aiinhealthcare #healthtech #cognitivehealth #boombostichealth #healthcareinnovation #healthcare

We keep acting like the mental health crisis and the spike in early-onset cancer are “mysterious.” They’re not. A huge chunk of the signal is sitting in your gut — and almost nobody in mainstream healthcare is looking at it. Mental health, early-onset cancer, autoimmunity—much of that risk is already visible in the gut years before a diagnosis code ever hits the chart. Most care models, benefits designs, and longevity strategies simply don’t account for it. Key Takeaways: * Why the microbiome is one of the most underused data layers in healthcare * How GutID turns gut health into a baseline, score, and trackable metric over time * How high-resolution microbiome data + AI unlock truly preventive diagnostics * Practical use cases: behavioral health, functional medicine, dietitians, and primary care * How gut data can inform smarter decisions around antibiotics and probiotics In this episode of Boombostic Health, I sit down with Paul Denslow, CEO & co-founder of Intus Bio, to unpack why gut health isn’t mystical, it’s a data problem and how GutID is turning the microbiome into an actionable signal for prevention, mental health, and early-onset cancer risk. Chapters 00:00 – Opening + why this conference feels different 02:29 – The microbiome as the “ocean” we’ve barely explored 03:22 – Mental health, early-onset cancer, and gut disruption 04:23 – GutID, data, and turning gut health into a measurable score 06:21 – How lifestyle and food systems are reshaping our bacterial “you” 06:59 – Where GutID is used today: DTC, behavioral health, functional medicine 07:56 – Antibiotics, probiotics, and why you need a microbiome baseline 13:54 – Why “all disease begins in the gut” is looking more true than ever 14:42 – Recommendations inside the GutID report (no supplement upsell) 16:06 – Paying with FSA and the path to employer and plan adoption 16:31 – Moving from diagnosis to the prevention window 17:18 – Gut toxins, long-term risk, and the smoking/heart disease analogy 18:20 – Science, capital, and scaling microbiome-driven prevention 18:48 – Closing + where to learn more about GutID and Intus Bio About our guest: Paul Denslow is the CEO and co-founder of Intus Bio, the company behind GutID. With a background in finance and big data, Paul partnered with co-founder Mark Driscoll, a pioneer in next-generation sequencing, to build a platform that treats the microbiome as a hard data problem—not a mystery. Intus Bio’s GutID test and Titan 1 platform are used by clinicians and practitioners to generate high-resolution microbiome data that can be translated into actionable prevention and disease insights. Links & Resources * Learn more about GutID: https://www.gutid.com/collections/all * Learn more about Intus Bio: https://www.intusbio.com/gutid * Watch more Boombostic Health episodes: https://www.boombostichealth.com/podcast #boombostichealth #guthealth #datadriven #healthtech #microbiome #preventativecare #cancer #mentalhealth #healthcare #healthcareinnovation

Virtual care is scaling. AI is everywhere. But when lab completion falls from ~70% in-clinic to ~30% in virtual care, the whole model breaks. Virtual Care Without Labs Is Just Zoom - Even with AI. In this Boombostic Health in the Wild episode from HLTH 2025, Bradley Bostic sits down with Maitham Dib, founder of Junction, to unpack the "real" bottleneck: turning lab orders into lab results. They dig into how Junction: * White-labels lab infrastructure so any virtual or hybrid care model can deploy labs across all 50 states * Uses data from ~3.4 million lab tests annually to model what actually drives lab completion * Dynamically routes patients across PSC visits, at-home kits, and at-home phlebotomy - based on real-world behavior * Plugs into telehealth and AI agents that still need working diagnostic rails to be useful Chapters 00:00 – Lab in the basement, but core to care 02:00 – 70% in-clinic vs. ~30% virtual: the lab completion cliff 03:30 – Junction’s white-label “Amazon-style” lab experience 06:30 – Three modalities: PSC, at-home kits, at-home phlebotomy 08:20 – “Where is the software actually?” Models on 3.4M lab tests 09:40 – Doctors, AI agents, and the diagnostic infrastructure layer 11:00 – Telehealth, pharma, and diagnostics as a new access door 12:40 – Business model: a new cost in a system that hates new costs Key Takeaways * Virtual care without completed labs is just Zoom. When fulfillment drops from ~70% in-clinic to ~30% in virtual, diagnosis and revenue leak out. * The real AI bottleneck is diagnostics.Agents and navigation tools only work if they can talk to lab infrastructure that actually gets tests done. * Infrastructure beats slogans.White-labeled, data-driven lab rails that convert orders to results are where virtual care and AI either succeed—or quietly fail. #boombostichealth #virtualcare #telehealth #digitalhealth #digitalhealthcare #healthcareinnovation #aiinhealthcare #patientcare #valuebasedcare #healthcare

Virtual care isn’t a feature. It’s the future care model nobody in healthcare wants to admit is already here. This conversation exposes three uncomfortable truths in healthcare: 1. Access is still broken. Millions delay care because transportation, work schedules, stigma, or geography get in the way. 2. Telemedicine wasn’t enough. Single-visit, transactional virtual care doesn't build trusted relationships, close care gaps, or keep patients inside a system of care. 3. Health systems are missing billions in preventable leakage. Ovation’s “digital health home” model quietly fixes that. At HLTH 2025, we sat down with Michael Dalton, CEO and founder of Ovatient, to unpack the real story behind why rural and urban patients alike are falling through the cracks and how Ovatient built the first truly integrated virtual multi-specialty practice on Epic. Dalton breaks down why: • A virtual-first care model that’s integrated directly into Epic makes specialists accessible within hours, not months • 95% of patients can be supported at home while still remaining inside their health system • Weight management, behavioral health, primary care, and specialty care all operate seamlessly across one unified patient journey • Virtual care isn’t cannibalizing brick-and-mortar — it’s expanding the funnel If you care about access, equity, referral management, or the economics of keeping patients connected to a system of care… this episode will challenge everything you think you know about “telemedicine.” Chapters 00:00 Introduction to Ovatient and Its Purpose 01:49 The Virtual Multi-Specialty Care Model 05:36 Integration with Health Systems 09:19 Building Trust in Healthcare 12:29 Closing Care Gaps with E-Consults Learn more: https://ovatient.com/ https://www.boombostichealth.com/ If you care about access, equity, referral management, or the economics of keeping patients connected to a system of care… this episode will challenge everything you think you know about “telemedicine.” Ovatient isn’t building a digital front door. They’re building the digital health home. And it’s changing the game. 🎧 Listen now and rethink everything you thought “virtual care” meant. #hlth2025 #boombostichealth #healthcareinnovation #virtualcare #healthsystems #digitalhealth #futureofcare #accesstocare

AI will accelerate healthcare — but genomics will rewrite it. The minute DNA drives care decisions for everyone, the current system becomes obsolete. Gene by Gene quietly runs one of the most advanced, high-throughput genomics labs in the world — powering platforms like MyHeritage and rapidly transforming clinical medicine, oncology, pharmacogenomics, and ancestry. This conversation explores what happens when every person leaves the hospital with a genomic passport — a lifelong DNA profile they own, control, and use to prevent disease before it begins. This is preventive medicine at scale. Not someday — now. What You’ll Learn - Why the genomics industry just flipped overnight - How AI + sequencing will routinely identify disease risk decades early - What happens when every patient controls their genomic data - How pharmacogenomics improves medication safety and outcomes - Why the healthcare system can’t keep up with genomic progress Chapters 00:00 – Live at HLTH 2025 00:29 – The quiet giant behind global genomics 01:20 – From physician to entrepreneur 02:45 – Acquiring Gene by Gene 04:19 – The massive shift to whole-genome sequencing 05:59 – Why more data = better diagnosis and prevention 07:30 – DecisionRx partnership and real-world outcomes 08:19 – Cost, speed, and modularity as the winning edge 09:52 – Sequencing every newborn at birth 11:00 – Data democratization and genomic ownership 11:59 – AI + 3 billion base pairs: why machines must lead 13:24 – Polygenic risk scoring and preventive cardiology 15:38 – Cognitive health and early-intervention models 16:40 – Nutrition + genomics: personal story 17:50 – Sleep, diet & medication metabolism 18:25 – Closing thoughts and future collaboration Learn more: https://www.boombostichealth.com/ https://www.genebygene.com/ #genomics #precisionmedicine #boombostichealth #DNARevolution #healthcareinnovation #futureofhealthcare #preventivemedicine #healthtech #biotechnology #artificialintelligence

Pharma Isn’t Broken — Access Is | ixlayer x Sanofi Ventures @ HLTH 2025 Patients don’t suffer because we lack medical innovation — they suffer because it takes too long to access it. 🚀 Why This Matters Patients today are consumers — they expect speed, personalization, and access. Pharma, technology, and venture capital are aligning to deliver it. The future of healthcare is collaborative, data-driven, and patient-first. Live from HLTH 2025 in the Diagnostic Zone, we dig into the real barriers between patients and lifesaving therapies. This episode covers: - How digital platforms reduce barriers to treatment - How AI is fueling proactive, personalized care - Why strategic capital accelerates patient-impact innovation Featuring: Pouria Sanae — Co-Founder & CEO, ixlayer Cris De Luca — Sanofi Ventures ⏱️ Timestamps 00:00 — Live at HLTH: Rethinking the pharma-patient connection 02:18 — Why patient access is the real bottleneck 04:20 — Sanofi Ventures: inside the strategic innovation model 06:45 — The truth about time-to-treatment in America 08:40 — The evolution of ixlayer & diagnostics infrastructure 10:30 — Can big pharma really go patient-first? 12:00 — Evidence, outcomes & trust in AI + health tech Connect & Learn More ixlayer.com - Revolutionizing patient access to diagnostics & treatment sanofiventures.com - Leading global strategic healthcare venture fund boombostichealth.com - Conversations at the edge of healthcare innovation 🎧 Listen & Subscribe Never miss an episode where we challenge the status quo in healthcare and spotlight the innovators building what’s next. 🧠 Healing Healthcare™ starts with bold ideas — and the courage to build them. #healthcareinnovation #digitalhealth #patientaccess #boombostichealth #aiinhealthcare #healthtech #pharmainnovation #futureofhealthcare #hlth2025 #hlthusa #PrecisionMedicine

Prescription costs are broken — and patients are the ones paying the price. In this episode of Boombostic Health, host Bradley Bostic sits down with Lathe Bigler of First Data Bank to unpack why e-prescribing hasn’t evolved in decades, how opaque pricing keeps patients in the dark, and why the next wave of pharmacy network innovation could flip the power dynamic back to patients. 💡 What We Cover: Why patients are frustrated with rising prescription costs How transparency empowers patients with real choices What most people don’t know about paying cash for prescriptions How e-prescribing networks can break pharmacy bottlenecks The role of technology in creating competition — and lowering costs This isn’t just about convenience. It’s about rebuilding trust in the healthcare system. Chapters 00:00 Introduction to Boombostic Health and Conference Atmosphere 08:23 Innovations in e-Prescribing Networks 14:59 The Importance of Transparency and Choice in Healthcare #boombostichealth #healthcareinnovation #PrescriptionTransparency #digitalhealth #patientempowerment #healthcaretechnology #prescriptioncosts #FirstDataBank #healthcaretechnology #healthcareleadership

Day 2 of #HLTHUSA in Las Vegas brought incredible energy, inspiring conversations, and some of the brightest minds in healthcare innovation. We took Boombostic Health: In the Wild onto the show floor to talk with leaders who are challenging the status quo and reimagining what’s possible in healthcare — from AI and data infrastructure to precision medicine, virtual care, and beyond. 🎙️ Featured Guests: - Lathe Bigler, General Manager, FDB Vela - Dr. Toby Basey-Fisher, CEO, Entia - Michelle Zimmerman, CEO, Previvor Edge - Dr. Geoffrey Rutledge, Cofunder & Chief Medical Officer, HealthTap - Bob Watson, CEO, Health Gorilla - Simon Arkell, CEO, Ryght.ai - James York, Chief Commercial Officer, Molecular Testing Labs - Fawad Butt, CEO, Penguin AI Each guest brought a unique perspective on how technology, leadership, and bold thinking are reshaping the business of healthcare. ✨ Filmed live at HLTH in Las Vegas — where the future of healthcare is being imagined and built. #boombostichealth #HLTH2025 #HLTHUSA #healthcareinnovation #futureofhealthcare #leadership #aiinhealthcare #digitalhealth #healthtech #innovation #lasvegas #healthcareleadership

Summary This conversation explores the transformative potential of AI in healthcare, emphasizing the importance of agentic AI, interoperability, and the need for a shift in medical education. The speakers discuss the challenges and opportunities presented by AI technologies, the necessity of upskilling healthcare professionals, and the economic models that must evolve to support these changes. They highlight the importance of viewing information as an asset and the role of AI in enabling personalized, longitudinal care for patients. Takeaways - There's always a new challenge to overcome in healthcare. - Mistakes often provide the best learning opportunities. - Agentic AI is set to transform healthcare significantly. - AI should enhance, not replace, human interaction in care. - 80% of clinicians' time is spent on administrative tasks. - Interoperability is crucial for effective patient care. - AI can synthesize vast amounts of data for better outcomes. - Investment in healthcare needs to focus on outcomes, not just costs. - Medical education must evolve to prioritize preventive care. - AI can turn healthcare from episodic to longitudinal care. Sound Bites "You learn so much more often from your mistakes." "AI allows us to synthesize a lot more data." "Information is ultimately an asset." Chapters 00:00 The Knothole Metaphor: Personal Drive and Motivation 02:57 Transformational Technology: The Impact of Agentic AI 05:38 AI in Healthcare: Redefining Roles and Responsibilities 08:43 Interoperability: The Key to Better Clinical Care 11:50 AI Integration: Upskilling and Workflow Automation 14:39 AI Native Applications: The Future of Healthcare Technology 17:42 Longitudinal Care: The Role of AI in Patient Management 20:32 Investment in Healthcare: Shifting Economic Models 23:37 The Future of Medical Education: A New Paradigm 26:31 Conclusion: The Bright Future of AI in Healthcare #healthcare #ai #agenticai #interoperability #medicaleducation #technology #patientcare #healthcaretransformation #digitalhealth #boombostichealth

Giving AI a ‘maternal instinct’ sounds strange… but it raises a real question: who decides how AI thinks in healthcare? 🧠 “Maternal instinct” for AI? Smarter than us… but will it care? ⚡ The first time in history we’ve built something more intelligent than ourselves. 💡 Who decides how it thinks — and whether it protects patients? 🔎 Why most AI initiatives in healthcare are failing. 🔥 No-code solutions + human oversight may be the only guardrails we have. #BoombosticHealth #AI #HealthcareInnovation #DigitalHealth #HealthTech #AINative #hc1

The business of healthcare is broken — but artificial intelligence might finally fix it. In this episode of Boombostic Health, Bradley Bostic and Jason Wenell reveal how to build an AI-ready healthcare system that learns, adapts, and delivers real value. Jason shares his three-layer framework — upskill people, automate workflows, and build AI-native systems that think. Discover how AI is becoming the engine behind value-based care and what it means for the future of healthcare innovation. Takeaways - AI is revolutionizing healthcare and other industries. - Value-based care relies heavily on data and predictive analytics. - AI can help identify social determinants of health. - Upskilling healthcare professionals is crucial for AI integration. - AI native applications will define the future of healthcare technology. - Data is considered the new oil in the healthcare sector. - Personalized healthcare will improve patient outcomes significantly. - AI should enhance human capabilities, not replace them. - Ethical considerations in AI development are paramount. - The future of healthcare is promising with the right AI applications. Chapters 00:00 Introduction to AI in Healthcare 03:13 AI Applications in Value-Based Care 06:04 Navigating Change Management in Healthcare 09:00 The Shift to AI Native Applications 11:49 Data as the New Oil in Healthcare 15:00 Personalized Healthcare Through AI 18:05 Transitioning to AI Native Solutions 20:59 Ethical Considerations in AI Development 24:05 The Future of Human-Centric Healthcare www.boombostichealth.com https://linktr.ee/BradleyBostic www.hc1.com linkedin.com/in/bradleybostic #boombostichealth #aihealthcare #healthcare #digitalhealth #healthcareinnovation #healthtech #valuebasedcare #ai

Why over 100 million Americans don’t have a primary care doctor, and how that drives up costs and worsens outcomes. In this conversation, Craig Hittle discusses the evolving nature of telemedicine, emphasizing that it should not be viewed merely as a transactional service. Instead, he advocates for a model that fosters long-term relationships between patients and healthcare providers, enhancing the overall quality of care delivered through digital platforms. Chapters 00:00 Introduction to Health Tap and Primary Care Innovations 04:16 The State of Primary Care in America 05:08 The Rise of Telemedicine and Its Impact 09:30 Telemedicine: A Shift in Patient Care Dynamics 12:39 Understanding the Durbin Report and Its Implications 15:35 Chronic Condition Management and Telehealth 17:58 The Role of AI in Enhancing Patient Care 21:11 Genomic Information in Primary Care 24:16 The Future of Telemedicine and Patient Relationships 28:26 Challenges and Opportunities for Primary Care Doctors 34:08 Value-Based Care: Aligning Incentives for Better Health 36:18 Sequence 01.mp4 Takeaways - Telemedicine is often misunderstood as purely transactional. - The goal of telemedicine should be to build relationships. - Long-term relationships with providers can improve patient care. - Telemedicine can enhance accessibility to healthcare services. - Establishing trust is crucial in telehealth interactions. - Patients should feel connected to their providers through telemedicine. - Digital health platforms can facilitate ongoing care. - The future of healthcare includes a blend of in-person and virtual visits. - Effective communication is key in telehealth. - Telemedicine can lead to better health outcomes when used correctly. #telemedicine #healthcareinnovation #boombostichealth #digitalhealth #digitalhealthcare

Every year in the U.S., 275,000 people die because of medication mismanagement — a failure that drains $528 billion annually from our $5 trillion healthcare system. It’s healthcare’s deadly hidden failure. That’s where DecisionRx comes in. Their coined Medication Therapy Optimization (MTO) approach goes far beyond Pharmacogenetics (PGx), combining AI-powered insights with pharmacist-led care to stop the guesswork, lower risk, and deliver results at scale. “The $528B isn’t in pill prices. It’s in ER visits, hospital admissions, and complications that never had to happen.” — Mike Tilton In this episode, host Bradley Bostic sits down with Mike Tilton, Chief Growth Officer at DecisionRx, to unpack the problem and spotlight the fix that’s delivering: - 8–10% reduction in total healthcare costs - 94% patient satisfaction - Maximum savings with minimal abrasion What You’ll Learn - Why $528B is being lost annually to preventable medication mismanagement. - How DecisionRx’s MTO model fixes the problem holistically — not just by swapping pills. - Why ER visits, hospitalizations, and complications drive the real costs. - Randall’s story: from 18 prescriptions and $12K/month to a sustainable regimen that restored his health. - How DecisionRx’s shared-savings model makes adoption possible even for financially strapped health systems. 📌 Episode 43 Chapters 00:00 – Intro: The $528B Fix 00:26 – 275,000 Preventable Deaths 01:57 – Mike Tilton’s Path to DecisionRx 04:44 – Healthcare’s $5T Problem 06:20 – Where $528B in Savings Hides 09:21 – MTO: Beyond Guessing Meds 12:59 – Randall’s Story 18:47 – Shared-Savings Model 22:49 – 94% Patient Satisfaction 26:31 – The Future: Concierge Pharmacy 31:27 – Closing: From Guesswork to Precision Medication mismanagement is killing us. DecisionRx has the fix. 👉 Learn more at decisionrx.com Subscribe to Boombostic Health for bold conversations that expose healthcare’s failures — and the solutions that can finally change it. #BoombosticHealth #valuebasedcare #MedicationOptimization #medicationsafety #pharmacogenomics #patientsafety #HealingHealthcare #healthcareinnovation #healthtech #digitalhealth #futureofhealthcare #healthequity

What is Real-World Data (RWD) in Medical Devices? It’s the information collected from everyday care — electronic health records, procedure notes, even how devices are used in emergencies — not just from controlled clinical trials. Why it matters to you: RWD shows how devices actually work in real people, not just in ideal test groups. - It helps doctors discover new ways to use existing devices — sometimes saving lives in unexpected situations. - It keeps life-saving tools on the market by proving their value, even when running huge clinical studies would be too costly. - It means safer, faster innovation — so patients benefit sooner. 👉 Without RWD, some devices could disappear simply because it’s too expensive to prove they work. With RWD, we protect access to life-saving care and give patients better outcomes. Pre-market clinical trials are essential — but they don’t reflect how devices truly perform once they’re in the real world. In this episode of Boombostic Health, host Bradley Bostic sits down with Dr. Amelia Hufford, Co-Founder and SVP of Clinical and Regulatory Science at 3Aware, to unpack why real-world data (RWD) is critical to the survival of medical devices — and why mindset, not science, may be the biggest barrier holding MedTech back. Amelia shares her 20+ year journey in scientific and clinical research, including a decade in MedTech leading regulatory and clinical affairs. She explains how RWD fills the gaps left by clinical trials, supports post-market surveillance, uncovers off-label use, and even opens the door to label expansion — giving manufacturers faster, less costly ways to prove safety and effectiveness. The conversation dives into the risks of ignoring RWD, the opportunities it creates for innovation and revenue, and how this shift could save one-third of devices currently at risk of disappearing from the market. What You’ll Learn in This Episode - Why pre-market clinical trials don’t fully reflect everyday device usage. - How real-world data provides insights into broader and more diverse patient populations. - Why manufacturers fear off-label data — and how it can actually unlock new markets. - The importance of treating RWD studies with the same rigor as traditional clinical research. - How RWD can accelerate innovation, improve patient outcomes, reduce costs, and support regulatory compliance. Why It Matters Without embracing real-world data, the MedTech industry risks losing critical devices — some of which save lives in high-stakes scenarios. By shifting mindset and using RWD with scientific rigor, manufacturers can not only ensure patient safety but also unlock growth opportunities, accelerate label expansion, and meet regulatory demands more efficiently. Resources & Links Learn more about 3Aware: https://3aware.ai/ Connect with Dr. Amelia Hufford on LinkedIn: https://www.linkedin.com/in/amelia-hufford-46181020/ Follow Bradley Bostic on LinkedIn https://www.linkedin.com/in/bradleybostic/ Subscribe on LinkedIn for weekly newsletter: https://www.linkedin.com/newsletters/7259254152554250241/ #medtech #RealWorldEvidence #healthcareinnovation #medicaldevices #3Aware #boombostichealth #rwe

The Dangerous Reality of Maternal Care in America. Did you know up to 80% of mothers are anemic by the 3rd trimester? And Black & Native mothers die at 49.5 per 100,000 births vs 19 for white mothers. These risks are preventable—yet our system still misses them. Giving birth in the U.S. is riskier than it should be. - 18% of mothers show anemia in the 1st trimester - By the 3rd trimester, that number explodes to 80% - Black & Native mothers: 49.5 deaths per 100,000 births - White mothers: 19 per 100,000 births Why It Matters Every statistic in this episode represents mothers, babies, and families forever changed. Tiffany’s message is clear: maternal deaths and injuries in the U.S. are preventable—but only if we address hidden risks early and make proactive care the standard. Chapter Highlights: 00:00 – Intro & Guest 01:57 – Tiffany’s Background 04:46 – Mothers & Babies at Risk 05:29 – Broken U.S. Care System 08:18 – 49.5 vs 19: The Disparity 10:09 – Hidden Risk: Anemia 11:57 – How HerCare Works 19:23 – Awareness & Policy Change 22:07 – The Future of Maternal Care 27:56 – Closing & Takeaways In this episode, Bradley Bostic sits down with Tiffany Hall, nurse and Director of cPBM Clinical Technology at hc1, to uncover the hidden pregnancy risks fueling maternal deaths — and how HerCare powered by MyBloodHealth helps providers act earlier to save both mothers and babies. 👉 What do YOU think needs to change first: policy, technology, or provider workflows? What You’ll Learn in This Episode: 📊 The shocking stats: anemia’s rise from 18% in the 1st trimester to 80% by the 3rd ⚠️ How anemia fuels hemorrhage, cardiovascular problems, and postpartum depression ✊ Why Black and Native mothers face mortality rates more than 2X higher than white mothers 🧪 How lab-driven insights can flip care from reactive to proactive 💡 How HerCare simplifies provider workflows and closes dangerous gaps in maternal care #pregnancy #maternalcare #maternalmortality #pregnancyrisks #healthcareinnovation #boombostichealth #MyBloodHealth #pregnancyjourney #pregnant #maternalcare #maternalhealth